Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
700 participants
OBSERVATIONAL
2020-07-01
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Factors After Liver Transplantation
NCT05018741
Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts
NCT07101718
Orthotopic Liver Transplantation Using a Living Donor
NCT00152607
A Worldwide Score for Hepatocellular Cancer and Liver Transplantation
NCT03595345
Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation
NCT02023190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Living Donor Liver Transplant Recipient
Patients who have received a living donor liver transplant.
Living Donor
Living Donor Organ Transplant
Deceased Donor Liver Transplant Recipient
Patients who have received either a Deceased by Circulatory Death or Deceased by Brain Death Liver Transplant
Cadaveric
Cadaveric Organ Transplant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cadaveric
Cadaveric Organ Transplant
Living Donor
Living Donor Organ Transplant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ibtesam Hilmi
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Montefiore
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY20070432
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.